TCM therapies combined with chemotherapy for preventing recurrence and metastasis in postoperative II to IIIA NSCLC: A protocol for a systematic review and meta-analysis

BACKGROUND: Traditional Chinese Medicine (TCM) therapies have been combined with chemotherapy for preventing Recurrence and metastasis in postoperative II to IIIA non-small-cell lung cancer (NSCLC) and the associated better disease-free survival (DFS), but its effects remain elusive. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuntai, Zhang, Zhenhua, Zhang, Xiwen, Qi, Runzhi, Jiang, Juling, Zhang, Xing, Xi, Yupeng, Liu, Rui, Guo, Qiujun, Zheng, Honggang, Hua, Baojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831319/
https://www.ncbi.nlm.nih.gov/pubmed/30817619
http://dx.doi.org/10.1097/MD.0000000000014724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831319/
https://www.ncbi.nlm.nih.gov/pubmed/30817619
http://dx.doi.org/10.1097/MD.0000000000014724

Ejemplares similares